Black women may undergo aggressive treatment regimens needed to treat late-onset cancers (black women are more likely than women of other races to be diagnosed with late-stage breast cancer) and difficult-to-treat cancers (eg, estrogen-receptor-negative or triple negative tumors) (18). This evidence concerns the gene ESR1 and cancer.